Neurocrine Biosciences | 운영 비용

주가
135.40
매일 변경
-2.25 -1.63%
매월
2.07%
매년
15.88%
Q1 예상
136.87




운영 비용 변화 날짜
AbbVie USD 10.81B 13.45B 2025-12
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Agios Pharmaceuticals USD 129.75M 9.76M 2025-09
ALKERMES USD 1.73B 1.44B 2025-09
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Amgen USD 5.9B 773M 2025-12
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Cytokinetics USD 168.69M 9.58M 2025-09
Dynavax Technologies USD 73.6M 7.41M 2025-09
Enanta Pharmaceuticals USD 79.28M 14.26M 2025-06
Exelixis USD 362.75M 21.35M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Halozyme Therapeutics USD 136.34M 13.06M 2025-09
Incyte USD 1.12B 3.53B 2025-12
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 555.6M 13.7M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
Prothena USD 42.18M 14.25M 2025-09
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Repligen USD 176.13M 279K 2025-09
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
Vertex Pharmaceuticals USD 1.84B 27.1M 2025-09
Xoma USD 22.84M 1.67M 2024-09


Neurocrine Biosciences 운영 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.